Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-12 Sale |
2025-03-13 8:00 pm |
Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director |
2,491 | $99.64 | $248,203 | 27,812 (Direct) |
View |
| 2024-12-12 Sale |
2024-12-16 8:00 pm |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
10,500 | $124.84 | $1,310,820 | 22,840 (Direct) |
View |
| 2024-12-05 Sale |
2024-12-06 8:00 pm |
Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director |
1,636 | $125.55 | $205,400 | 5,880 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-12 Exercise |
2025-03-13 8:00 pm |
2016-06-02 2025-06-02 |
Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director |
9,746 | $0 | 27,812 (Direct) |
View |
| 2025-03-12 Exercise |
2025-03-13 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director |
9,746 | $25.18 | 27,812 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Connelly Deirdre P Director |
7,175 | $0 | 10,017 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director |
7,175 | $0 | 13,055 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director |
7,175 | $0 | 299,486 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel |
24,920 | $0 | 37,754 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel |
491 | $100.13 | 37,754 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
24,920 | $0 | 79,256 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
5,500 | $0 | 79,256 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
3,941 | $100.13 | 79,256 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
7,175 | $0 | 30,015 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director |
7,175 | $0 | 13,796 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
24,920 | $0 | 49,144 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
523 | $100.13 | 49,144 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
24,920 | $0 | 101,275 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
5,500 | $0 | 101,275 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
3,463 | $100.13 | 101,275 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
24,920 | $0 | 54,846 (Direct) |
View |
| 2025-03-07 Exercise |
2025-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
5,500 | $0 | 54,846 (Direct) |
View |
| 2025-03-10 Tax Withholding |
2025-03-11 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
3,733 | $100.13 | 54,846 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Barry Richard Director |
7,175 | $0 | 3,188,863 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director |
7,175 | $0 | 41,114 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-11 8:00 pm |
2026-03-10 2035-03-10 |
Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director |
7,175 | $0 | 208,268 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
17,500 | $0 | 52,777 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
9,679 | $103.7 | 52,777 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
17,500 | $0 | 74,318 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
8,504 | $103.7 | 74,318 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel |
1,478 | $103.7 | 11,847 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
17,500 | $0 | 28,159 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
9,162 | $103.7 | 28,159 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
17,500 | $0 | 24,747 (Direct) |
View |
| 2025-03-07 Tax Withholding |
2025-03-10 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
9,035 | $103.7 | 24,747 (Direct) |
View |
| 2025-03-04 Tax Withholding |
2025-03-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel |
584 | $101.34 | 13,325 (Direct) |
View |
| 2025-03-04 Tax Withholding |
2025-03-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
514 | $101.34 | 16,282 (Direct) |
View |
| 2025-03-04 Tax Withholding |
2025-03-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
1,685 | $101.34 | 19,821 (Direct) |
View |
| 2025-03-04 Tax Withholding |
2025-03-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
1,370 | $101.34 | 44,956 (Direct) |
View |
| 2025-03-04 Tax Withholding |
2025-03-06 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
1,704 | $101.34 | 65,322 (Direct) |
View |
| 2025-03-03 Tax Withholding |
2025-03-04 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
711 | $103.77 | 21,506 (Direct) |
View |
| 2025-03-03 Tax Withholding |
2025-03-04 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
719 | $103.77 | 16,796 (Direct) |
View |
| 2025-03-03 Tax Withholding |
2025-03-04 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
557 | $103.77 | 46,326 (Direct) |
View |
| 2025-03-03 Tax Withholding |
2025-03-04 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
715 | $103.77 | 67,026 (Direct) |
View |
| 2025-03-03 Tax Withholding |
2025-03-04 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel |
391 | $103.77 | 13,621 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
3,500 | $0 | 17,500 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
3,500 | $0 | 17,500 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Murray Dallan Chief Customer Officer |
3,500 | $0 | 17,500 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer |
3,500 | $0 | 17,500 (Direct) |
View |
| 2025-01-29 Tax Withholding |
2025-01-31 8:30 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
2,613 | $117.51 | 46,883 (Direct) |
View |
| 2025-01-29 Exercise |
2025-01-31 8:30 pm |
2016-01-30 2025-01-30 |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
15,800 | $0 | 46,883 (Direct) |
View |
| 2025-01-29 Exercise |
2025-01-31 8:30 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
15,800 | $12 | 46,883 (Direct) |
View |
| 2024-12-27 Gift |
2024-12-30 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer |
250 | $0 | 33,696 (Direct) |
View |
| 2024-12-12 Exercise |
2024-12-16 8:00 pm |
2017-02-28 2026-02-28 |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
10,500 | $0 | 22,840 (Direct) |
View |
| 2024-12-12 Exercise |
2024-12-16 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director |
10,500 | $13.71 | 22,840 (Direct) |
View |
| 2024-11-26 Option Award |
2024-11-29 8:15 pm |
2025-11-26 2034-11-26 |
Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel |
6,000 | $0 | 17,817 (Direct) |
View |
Ownership |
2024-11-29 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rothfuss Cristin EVP, General Counsel |
0 | $0 | 39,916 (Direct) |
View |
| 2024-11-18 Tax Withholding |
2024-11-20 8:00 pm |
N/A N/A |
Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO |
4,558 | $102.89 | 67,630 (Direct) |
View |